David L. Davis

4.3k total citations · 1 hit paper
19 papers, 2.3k citations indexed

About

David L. Davis is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, David L. Davis has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in David L. Davis's work include bioluminescence and chemiluminescence research (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Alzheimer's disease research and treatments (3 papers). David L. Davis is often cited by papers focused on bioluminescence and chemiluminescence research (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Alzheimer's disease research and treatments (3 papers). David L. Davis collaborates with scholars based in United States. David L. Davis's co-authors include Ivan Lieberburg, R E Rydel, MP Mattson, Katherine Bryant, Bin Cheng, Douglas Galasko, Lawrence C. Fritz, Leon J. Thal, Dale B. Schenk and Tilman Oltersdorf and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

David L. Davis

18 papers receiving 2.2k citations

Hit Papers

beta-Amyloid peptides destabilize calcium homeostasis and... 1992 2026 2003 2014 1992 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
    1992 1.4k citations MP Mattson, Bin Cheng et al. Journal of Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Davis United States 12 1.7k 1.0k 656 627 336 19 2.3k
Donald B. Carter United States 20 1.2k 0.7× 969 0.9× 474 0.7× 488 0.8× 344 1.0× 44 2.3k
Tobun T. Cheung United States 6 2.3k 1.4× 1.4k 1.4× 410 0.6× 594 0.9× 421 1.3× 7 2.7k
Günter Tremp France 19 1.6k 1.0× 967 0.9× 722 1.1× 401 0.6× 206 0.6× 29 2.3k
Joseph V. Kosmoski United States 9 1.7k 1.0× 1.4k 1.3× 276 0.4× 390 0.6× 336 1.0× 9 2.4k
Thomas Dyrks Germany 21 1.8k 1.0× 1.1k 1.1× 388 0.6× 436 0.7× 215 0.6× 32 2.3k
Arlene M. Manelli United States 20 2.2k 1.3× 1.4k 1.4× 666 1.0× 499 0.8× 355 1.1× 29 3.0k
Benjamin McDonald Australia 7 3.0k 1.8× 1.8k 1.8× 547 0.8× 656 1.0× 529 1.6× 13 3.7k
Wesley Farris United States 10 1.9k 1.1× 987 1.0× 416 0.6× 485 0.8× 213 0.6× 11 2.7k
Colin L. Masters Australia 14 1.2k 0.7× 850 0.8× 279 0.4× 317 0.5× 212 0.6× 16 1.5k
John W. Kusiak United States 25 1.1k 0.7× 1.3k 1.2× 743 1.1× 288 0.5× 94 0.3× 58 2.3k

Countries citing papers authored by David L. Davis

Since Specialization
Citations

This map shows the geographic impact of David L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Davis more than expected).

Fields of papers citing papers by David L. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Davis. The network helps show where David L. Davis may publish in the future.

Co-authorship network of co-authors of David L. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Davis. A scholar is included among the top collaborators of David L. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Davis. David L. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hom, Roy K., Jay S. Tung, Donald E. Walker, et al.. (2003). Design and Synthesis of Hydroxyethylene-Based Peptidomimetic Inhibitors of Human β-Secretase. Journal of Medicinal Chemistry. 47(1). 158–164. 61 indexed citations
2.
Hom, Roy K., Jay S. Tung, David L. Davis, et al.. (2003). Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-Secretase. Journal of Medicinal Chemistry. 46(10). 1799–1802. 62 indexed citations
3.
Tung, Jay S., David L. Davis, John P. Anderson, et al.. (2001). Design of Substrate-Based Inhibitors of Human β-Secretase. Journal of Medicinal Chemistry. 45(2). 259–262. 71 indexed citations
4.
Davis, David L., Raymond F. Hamilton, & Andrij Holian. (1997). 4-Hydroxynonenal Inhibits Interleukin-1βConverting Enzyme. Journal of Interferon & Cytokine Research. 17(4). 205–210. 23 indexed citations
5.
Qureshi, Tariq R., et al.. (1995). ENZYME LINKED IMMUNO TRANSFER BLOT ANALYSI OF EXCRETORY - CECRETORY PROTEINS OF FASIOLOIDES MAGNA & FASCIOLA HEPATICA. 58. 357–363. 1 indexed citations
6.
Seubert, Peter, Tilman Oltersdorf, Robin Barbour, et al.. (1993). Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature. 361(6409). 260–263. 455 indexed citations
7.
Games, Dora, Karen Khan, Ferdie Soriano, et al.. (1992). Lack of alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiology of Aging. 13(5). 569–576. 112 indexed citations
8.
Mattson, MP, Bin Cheng, David L. Davis, et al.. (1992). beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience. 12(2). 376–389. 1390 indexed citations breakdown →
9.
Davis, David L., et al.. (1973). Evaluation of Centrifugal Chromatography I. Separation of Steroid Hormones on Silica Gel. Journal of Chromatographic Science. 11(8). 406–410. 2 indexed citations
10.
Tsuji, Frederick I., David L. Davis, & David Donald. (1969). Chromatographic Studies on Spleen and Lymph Node Extracts with Antibody Activity. The Journal of Immunology. 102(2). 519–529. 3 indexed citations
11.
Tsuji, Frederick I., David L. Davis, & David Donald. (1966). The Effect of Hydrostatic Pressure on the Rate of Inactivation of Cypridina Luciferase by Specific Antibody. The Journal of Immunology. 96(4). 614–621. 5 indexed citations
12.
Tsuji, Frederick I., David L. Davis, & E. Melvin Gindler. (1962). Effect of Sodium Chloride and pH on the Rate of Neutralization of Cypridina Luciferase by Specific Antibody. The Journal of Immunology. 88(1). 83–92. 12 indexed citations
13.
Tsuji, Frederick I., et al.. (1960). Kinetics of the Inhibition of Cypridina Luciferase by Specific Antibody,. The Journal of Immunology. 84(6). 615–625. 13 indexed citations
14.
Tsuji, Frederick I. & David L. Davis. (1959). A Quantitative Photometric Method for Studying the Reaction between Cypridina Luciferase and Specific Antibody,. The Journal of Immunology. 82(2). 153–160. 4 indexed citations
15.
Tsuji, Frederick I. & David L. Davis. (1958). Effect of Antibodies on the Luminescence of Achromobacter Fischeri as a Criterion of Cellular Penetration,. The Journal of Immunology. 81(3). 242–245. 2 indexed citations
16.
Foldes, Francis F., et al.. (1958). THE STRUCTURE-ACTION RELATIONSHIP OF URETHANE TYPE CHOLINESTERASE INHIBITORS. Journal of Pharmacology and Experimental Therapeutics. 122(4). 457–464. 11 indexed citations
17.
Foldes, Francis F., et al.. (1956). INFLUENCE OF HALOGEN SUBSTITUTION ON ENZYMATIC HYDROLYSIS. Anesthesiology. 17(1). 187–195. 20 indexed citations
18.
Foldes, Francis F., et al.. (1955). Hydrolysis of Ester-type Local Anesthetics and their Halogenated Analogs by Purified Plasma Cholinesterase1. Journal of the American Chemical Society. 77(19). 5149–5151. 13 indexed citations
19.
Foldes, Francis F., et al.. (1953). Substrate Competition between Procaine and Succinylcholine Diiodide for Plasma Cholinesterase. Science. 117(3041). 383–386. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald B. Carter Breakdown of academic impact, for papers by Tobun T. Cheung Breakdown of academic impact, for papers by Günter Tremp Breakdown of academic impact, for papers by Joseph V. Kosmoski Breakdown of academic impact, for papers by Thomas Dyrks Breakdown of academic impact, for papers by Arlene M. Manelli Breakdown of academic impact, for papers by Benjamin McDonald Breakdown of academic impact, for papers by Wesley Farris Breakdown of academic impact, for papers by Colin L. Masters Breakdown of academic impact, for papers by John W. Kusiak
Rankless by CCL
2026